MedPath
HSA Approval

PREGABALIN SANDOZ CAPSULES 75MG

SIN15359P

PREGABALIN SANDOZ CAPSULES 75MG

PREGABALIN SANDOZ CAPSULES 75MG

November 10, 2017

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

N03AX16

xn 03 ax 16

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Genveon Ilac Sanayi ve Ticaret A.S.

Salutas Pharma GmbH

Active Ingredients

PREGABALIN

75mg

Pregabalin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PREGABALIN SANDOZ CAPSULES 75MG - HSA Approval | MedPath